Authors
Fuhai Wu, Zhen Chen, Huan Chen, Yu Xing, Zhiyuan Liu, Xingye Lin, Guanzhe Wang, Dongchen Han, Shanshan Qiu, Zhenyuan Zhang, Yan Chen, Yunhao Ren, Zhixin Wu, Dongfang Xia, Kai Cao, Xuhu Huang, Hongyu Li, Xueyun Gao
Published in
Journal of medicinal chemistry. Volume 69. Issue 21. Pages 26302-26313. Nov 12, 2026.
Abstract
Carbonic anhydrase IX (CAIX) is a key biomarker for clear cell renal cell carcinoma (ccRCC) PET imaging. The reported probe 68Ga-DPI-4452 strongly targets both hCAIX and hCAII, therefore hindering its clinical applications. This study developed two optimized probes, 68Ga-WF1 and 68Ga-WF2. They have nanomolar affinity for hCAIX but far weaker binding to hCAII compared with that of 68Ga-DPI-4452. In OS-RC-2 tumor-bearing mice, the tumor uptake of 68Ga-WF1 and 68Ga-WF2 was comparable to that of 68Ga-DPI-4452. However, since 68Ga-WF2 exhibited the lowest affinity for mCAII and mCAIX, its gastrointestinal uptake was the lowest. The autoradiography result revealed that three probes strongly bound human ccRCC tissues, while 68Ga-WF1 and 68Ga-WF2 bound far less to digestive tract tissues. Due to the lowest affinity of 68Ga-WF1 for hCAII, it effectively reduces uptake in the human gastrointestinal tract, holding promise for high tumor contrast and low gastrointestinal tract toxicity for ccRCC PET imaging.
PMID:
43018574
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0